From November 2008 to September 2015, Dr. Adams administered the drug edetate calcium disodium for a wide range of conditions not recognized as treatable using that drug, according to an Oct. 12 news release from the Justice Department. After Medicare would not reimburse his use of edetate calcium disodium, he falsely claimed his patients were suffering from heavy metal poisoning.
A jury in June found Dr. Adams and his practice guilty of violating the False Claims Act. Medicare reimbursed more than $1.1 million for the medically unnecessary treatments and a federal judge added penalties to the jury’s verdict, bringing the total to more than $25.7 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.